T. Rowe Price Associates’s Revolution Medicines RVMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$314M Sell
3,232,213
-172,504
-5% -$17.4M 0.04% 351
2025
Q4
$271M Sell
3,404,717
-468,989
-12% -$30.8M 0.03% 379
2025
Q3
$181M Sell
3,873,706
-828,256
-18% -$32.4M 0.02% 483
2025
Q2
$173M Sell
4,701,962
-897,680
-16% -$34.5M 0.02% 465
2025
Q1
$198M Sell
5,599,642
-266,320
-5% -$10.8M 0.02% 420
2024
Q4
$257M Buy
5,865,962
+552,657
+10% +$27.9M 0.03% 376
2024
Q3
$241M Buy
5,313,305
+96,646
+2% +$4.21M 0.03% 397
2024
Q2
$202M Buy
5,216,659
+402,349
+8% +$15M 0.02% 415
2024
Q1
$155M Buy
4,814,310
+177,957
+4% +$5.27M 0.02% 468
2023
Q4
$133M Sell
4,636,353
-458,353
-9% -$11M 0.02% 495
2023
Q3
$141M Buy
5,094,706
+75,941
+2% +$2.25M 0.02% 451
2023
Q2
$134M Sell
5,018,765
-16,414
-0.3% -$403K 0.02% 474
2023
Q1
$109M Buy
5,035,179
+1,355,137
+37% +$33.4M 0.02% 493
2022
Q4
$87.7M Buy
3,680,042
+27,414
+0.8% +$583K 0.01% 519
2022
Q3
$72M Buy
3,652,628
+1,414,774
+63% +$31.1M 0.01% 554
2022
Q2
$43.6M Sell
2,237,854
-61,962
-3% -$1.21M 0.01% 920
2022
Q1
$58.7M Buy
2,299,816
+1,244,045
+118% +$27.1M 0.01% 917
2021
Q4
$26.6M Buy
1,055,771
+35,925
+4% +$1.01M ﹤0.01% 1209
2021
Q3
$28.1M Buy
1,019,846
+1,001,922
+5,590% +$29.2M ﹤0.01% 1198
2021
Q2
$569K Buy
17,924
+2,049
+13% +$71.5K ﹤0.01% 2332
2021
Q1
$728K Sell
15,875
-76,945
-83% -$3.45M ﹤0.01% 2195
2020
Q4
$3.67M Buy
+92,820
New +$3.67M ﹤0.01% 1487
2020
Q3
Sell
-133,371
Closed -$4.21M 2621
2020
Q2
$4.21M Buy
133,371
+37,939
+40% +$1.19M ﹤0.01% 1402
2020
Q1
$2.09M Buy
+95,432
New +$2.64M ﹤0.01% 1489

Other funds holding RVMD